BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012

Jun 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-06-05

Reporting Person: Jensen Peder (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-05	Common Stock	P	20000	$3.184	Acquired	40000	Direct

Footnotes

F1: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.1772 to $3.19. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.